Aveanna Healthcare (AVAH) Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last twelve months. There are currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" AVAH shares.
View AVAH analyst ratings or view top-rated stocks.

5 brokers have issued 1 year price targets for Aveanna Healthcare's shares. Their AVAH share price forecasts range from $1.00 to $3.00. On average, they expect the company's stock price to reach $1.98 in the next twelve months. This suggests a possible upside of 69.5% from the stock's current price.
View analysts price targets for AVAH or view top-rated stocks among Wall Street analysts.

Aveanna Healthcare's stock was trading at $0.78 at the beginning of the year. Since then, AVAH shares have increased by 50.0% and is now trading at $1.17.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our AVAH earnings forecast.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) issued its quarterly earnings results on Thursday, August, 10th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.02. The business had revenue of $471.95 million for the quarter, compared to analyst estimates of $453.19 million. Aveanna Healthcare had a negative net margin of 12.00% and a negative trailing twelve-month return on equity of 70.08%. During the same quarter in the previous year, the company posted $0.03 EPS.

Aveanna Healthcare updated its FY 2023 earnings guidance on Sunday, August, 20th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.85 billion-$1.86 billion, compared to the consensus revenue estimate of $1.87 billion.

(AVAH) raised $478 million in an initial public offering on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Aveanna Healthcare trades on the NASDAQ under the ticker symbol "AVAH."

Aveanna Healthcare's stock is owned by a number of institutional and retail investors. Top institutional investors include Nut Tree Capital Management LP (5.82%), Littlejohn & Co. LLC (3.42%), King Street Capital Management L.P. (2.00%), BlackRock Inc. (1.88%), Principal Financial Group Inc. (1.71%) and Geode Capital Management LLC (0.57%). Insiders that own company stock include David Afshar, Jeff Shaner, Patrick A Cunningham, Steven E Rodgers, Tony Strange and Victor F Ganzi.
View institutional ownership trends.

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AVAH stock can currently be purchased for approximately $1.17.

Aveanna Healthcare (NASDAQ:AVAH) has a market capitalization of $222.80 million and generates $1.79 billion in revenue each year. The company earns $-662,030,000.00 in net income (profit) each year or ($1.19) on an earnings per share basis.

The company employs 3,700 workers across the globe.

Aveanna Healthcare's mailing address is 400 INTERSTATE NORTH PARKWAY STE 1700, ATLANTA GA, 30339. The official website for the company is www.aveanna.com. The company can be reached via phone at 770-441-1580 or via email at ir@aveanna.com.